Drug Profile
BIO 140 - Onc Bio
Alternative Names: BIO140 - Onc BioLatest Information Update: 11 Jan 2008
Price :
$50
*
At a glance
- Originator Onc Bio
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Brain cancer
Most Recent Events
- 06 Oct 2005 Phase-I clinical trials in Brain cancer in USA (Intrathecal)